Patents by Inventor David R. Fischell

David R. Fischell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070208263
    Abstract: A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal. The systems receives data regarding the patient's state (e.g. asleep, exercising). Patient state information is stored in a patient state array, thereby enabling the system to track the patient's state over time, and to select an appropriate test for detecting a cardiac event based on both past and present data regarding the patient's state.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 6, 2007
    Inventors: Michael Sasha John, David R. Fischell, Bruce Hopenfeld
  • Patent number: 7252679
    Abstract: The present invention uses sets of strut members where the most distal set of strut members is similar to that of most stents in that the plane of the distal set of strut members is perpendicular to the stent's longitudinal axis. The present invention has a multiplicity of circumferential sets of strut members, but only the distal set of strut members has its plane perpendicular to the stent's longitudinal axis. The more proximal sets of strut members are angulated, so that the plane of the most proximal set of strut members has a preset angle such as 30°, 45° or 60° relative to the stent's longitudinal axis. The stent could also be formed from or coated with a highly radiopaque material. Alternately, a radiopaque marker could be placed at the most proximal point of the angulated, side branch stent, for the stent has to be rotated by the clinician until the plane of the most proximal angulated set of strut members is situated to be approximately parallel to the plane of the ostium of the side branch.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: August 7, 2007
    Assignee: Cordis Corporation
    Inventors: David R. Fischell, Robert E. Fischell, Tim A. Fischell
  • Patent number: 7169174
    Abstract: The present device has increased longitudinal flexibility in a stent by having some curved sections of each circumferential set of strut members being unconnected to the curved sections of the adjacent circumferential set of strut members with the other curved sections being connected by highly flexible, undulating longitudinal connecting links. The present device prevents flaring of the unconnected strut members by having a shorter longitudinal length for the unconnected strut members, and may have generally shorter longitudinal lengths for all the strut members in the circumferential sets of strut members at the stent ends to reduce the tendency for end flaring of the stent. Finally, the stent demonstrates that the flexible longitudinal connecting links of the curved sections of the sets of strut members are connected at a point that is close to the line where the diagonal sections join the curved sections, thus further reducing the propensity for end flaring.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: January 30, 2007
    Assignee: Cordis Corporation
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 7107096
    Abstract: A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal and a patient alarm is further provided and electrically coupled to the electrical signal processor. The patient alarm generates an escalating sensory alarm signal over a predetermined time period subsequent to the electrical signal processor if the processor detects a cardiac event. The patient alarm may be further applied to a pacemaker or defibrillator system.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: September 12, 2006
    Assignee: Angel Medical Systems, Inc.
    Inventors: David R. Fischell, Jonathan Harwood, Mary Carol Day
  • Patent number: 7060088
    Abstract: Disclosed is a stent that has flexible connecting links that have a strut width as measured in a direction that is generally along the surface of the stent that is smaller than the wall thickness of the stent as measured in a radial direction from the stent's longitudinal axis. The strut width for a coronary stent should be less than 0.10 mm to provide good flexibility while the wall thickness should be greater than 0.10 mm to provide good stent radiopacity. Ideally the ratio of the width to the thickness should be less than 1.0 and preferably less than 0.08 mm and the nominal wall thickness would typically be 0.12 mm. The combination of thin strut width and thick wall thickness will allow the flexible link to easily lengthen and shorten for increased stent flexibility while making the link relatively stiff with respect to bulging inward into the lumen of the stent. This stiffness enhances the ability of the link to push outward against plaque in a coronary artery after the stent is deployed.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: June 13, 2006
    Assignee: Cordis Corporation
    Inventors: Robert E. Fischell, David R. Fischell, David C. Majercak
  • Patent number: 7037327
    Abstract: A hybrid stent that is defined as having a central section that is balloon expandable and end sections that are self-expanding. The entire stent is mounted on a balloon of a balloon angioplasty catheter. One way to retain the self-expanding portion of the stent onto a balloon onto which it has been nested is to place a cylindrical elastomer tube around each of the self-expanding end sections of the stent.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: May 2, 2006
    Inventors: Sean Salmon, Dieter Stockel, Robert E. Fischell, Tim A. Fischell, David R. Fischell
  • Patent number: 7011673
    Abstract: The present invention is a stent delivery system that uses a short section of a guide wire that is fixedly attached to a distal section of a balloon angioplasty catheter. By not having a guide wire that slides through the balloon of the balloon angioplasty catheter, the balloon on which the stent is mounted can have a reduced diameter. Therefore, the outside diameter of the undeployed stent mounted onto that balloon is also minimized. This provides a minimum profile, i.e., a minimum outside diameter, for the stent. A minimum profile at the distal section of the stent delivery system is highly advantageous for improving the percentage of cases that can be treated by means of direct stenting; i.e., without requiring pre-dilation of a stenosis.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: March 14, 2006
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 6985771
    Abstract: Disclosed is a system for detecting an acute myocardial infarction (i.e., a heart attack) at the earliest possible time and promptly warning the patient that he should immediately seek medical care. The present invention includes an implantable electronic system that can sense a change in the patient's electrogram that is indicative of a heart attack. If a heart attack is sensed, the device would then cause an implantable and/or externally located alarm to be actuated to warn the patient of his condition and a medical practitioner at a remote diagnostic center would receive the patient's electrogram for analysis. The patient or a caretaker would then be informed to self-inject medication through a subcutaneous, pass-through drug port that can be a separate device or integrated into the implanted device that is designed for the early detection of a heart attack.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: January 10, 2006
    Assignee: Angel Medical Systems, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 6936065
    Abstract: The present invention is a stent delivery system that uses short section of guidewire fixedly attached to the distal section of a balloon angioplasty catheter onto which a stent is co-axially mounted. By not having a guidewire that slides through the balloon of the balloon angioplasty catheter, the deflated balloon on which the stent is mounted can have a reduced diameter. Therefore, the outer diameter of the pre-deployed stent mounted onto that balloon is also minimized. This provides a smaller profile, i.e., a smaller outer diameter, for the stent. The time to perform a stent delivery procedure is reduced; a separate guidewire does not have to be placed prior to using the stent delivery system to place the stent at the site of a stenosis. Another embodiment of the present invention has a core wire that extends for nearly the entire length of the stent delivery system, the guidewire having different levels of stiffness for different portions of the core wire's length.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: August 30, 2005
    Assignee: Cordis Corporation
    Inventors: I. John Khan, Robert Burgermeister, Robert E. Fischell, David R. Fischell
  • Publication number: 20040243226
    Abstract: A preferred embodiment of this invention is a stent that is coated with an anti-restenosis drug that is selected from the group that includes, Alkeran, Cytoxan, Leukeran, Cis-platinum, BiCNU, Adriamycin, Doxorubicin, Cerubidine, Idamycin, Mithracin, Mutamycin, Fluorouracil, Methotrexate, Thoguanine, Toxotere, Etoposide, Vincristine, Irinotecan, Hycamptin, Matulane, Vumon, Hexalin, Hydroxyurea, Gemzar, Oncovin, Etophophos, tacrolimus (FK506), and the following analogs of sirolimus: SDZ-RAD, CCI-779, 7-epi-rapamycin, 7-thiomethyl-rapamycin, 7-epi-trimethoxyphenyl-rapamycin, 7-epi-thiomethyl-rapamycin, 7-demethoxy-rapamycin, 32-demethoxy, 2-desmethyl and proline.
    Type: Application
    Filed: June 14, 2004
    Publication date: December 2, 2004
    Inventors: Robert E. Rischell, David R Fischell, Tim A. Fischell
  • Publication number: 20040241211
    Abstract: Disclosed is a cytostatic drug attached to a sterile sheet that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This sheet onto or into which the drug is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with an anti-proliferative drug such as sirolimus, the biodegradable, drug impregnated mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions or scar tissue. Another embodiment of this invention is a cytostatic drug attached to a sheet that is placed at the site of an anastamosis to decrease scar tissue formation from within the vessel at the site of the anastomosis.
    Type: Application
    Filed: February 11, 2002
    Publication date: December 2, 2004
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Publication number: 20040230294
    Abstract: A method for implanting a balloon expandable stent at a site within a passageway of a curved coronary article. The stent includes at least two longitudinally spaced apart circumferential rings. At least one longitudinally extending connector extends between adjacent rings. The connector has at least one turn back portion that can expand or contract in length while being passed through a curved passageway. The stent is disposed on a stent delivery catheter having an inflatable balloon. The stent delivery catheter and the stent is delivered through the passageway to the site of implementation with the connector member expanding or contracting in length to facilitate delivery and placement of the stent. The stent is expanded at the site of implantation by inflating the balloon to force the stent radially outward against the wall of the coronary artery.
    Type: Application
    Filed: September 15, 2003
    Publication date: November 18, 2004
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Publication number: 20040225345
    Abstract: The present invention consists of a main artery stent (the main stent) that is placed in the main artery and a second stent that is placed into the side branch (the side branch stent), the two stents constituting a complete treatment for a stenosed arterial bifurcation. Both stents are preferably drug eluting. The main stent would optimally be one that has a reasonably small area of each cell after the stent is deployed, but also has a large perimeter length for each cell. The stent delivery system for the side branch stent has an attached main guide wire tube that can be advanced over a main guide wire and a central lumen that is advanced over a guide wire placed into the side branch. The structure of the side branch stent delivery system allows the side branch stent to achieve the correct angular orientation and longitudinal position when it is advanced over the two guide wires.
    Type: Application
    Filed: December 9, 2003
    Publication date: November 11, 2004
    Inventors: Robert E. Fischell, Robert Burgermeister, David R. Fischell, Tim A. Fischell, Thomas N. Trotta, Scott Sidwell
  • Publication number: 20040215092
    Abstract: Disclosed is a system for the detection of cardiac events that includes an implanted device called a cardiosaver, a physician's programmer and an external alarm system. The system is designed to provide early detection of cardiac events such as acute myocardial infarction or exercise induced myocardial ischemia caused by an increased heart rate or exertion. The system can also alert the patient with a less urgent alarm if a heart arrhythmia is detected. Using different algorithms, the cardiosaver can detect a change in the patient's electrogram that is indicative of a cardiac event within five minutes after it occurs and then automatically warn the patient that the event is occurring. To provide this warning, the system includes an internal alarm sub-system (internal alarm means) within the cardiosaver and/or an external alarm system (external alarm means) which are activated after the ST segment of the electrogram exceeds a preset threshold.
    Type: Application
    Filed: May 26, 2004
    Publication date: October 28, 2004
    Inventors: David R. Fischell, Tim A. Fischell, Jonathan Harwood, Robert E. Fischell, Steven R. Johnson
  • Publication number: 20040204751
    Abstract: The present device has increased longitudinal flexibility in a stent by having some curved sections of each circumferential set of strut members being unconnected to the curved sections of the adjacent circumferential set of strut members with the other curved sections being connected by highly flexible, undulating longitudinal connecting links. The present device prevents flaring of the unconnected strut members by having a shorter longitudinal length for the unconnected strut members, and may have generally shorter longitudinal lengths for all the strut members in the circumferential sets of strut members at the stent ends to reduce the tendency for end flaring of the stent. Finally, the stent demonstrates that the flexible longitudinal connecting links of the curved sections of the sets of strut members are connected at a point that is close to the line where the diagonal sections join the curved sections, thus further reducing the propensity for end flaring.
    Type: Application
    Filed: February 3, 2004
    Publication date: October 14, 2004
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Publication number: 20040199212
    Abstract: Disclosed is a patient alerting device (PAD) that can be positioned close enough for effective near-field communication with an implanted medical device such as a pacemaker or implantable cardiac defibrillator. The PAD is designed to warn the patient when a specific event is detected by the implanted device. The alarm mechanism could be a sound, a vibration and/or a visible display. A communications repeater can be used with the PAD to allow the implanted device to communicate via the PAD with remotely located external equipment through proprietary or standardized means. Means to initiate communication with the implanted device include a magnet within the PAD that triggers a magnetic switch inside the implanted device or by a button which can be depressed to inform the implanted device that the PAD is active and close enough to begin communication. The PAD could also include a button to shut off an alarm that is in the PAD.
    Type: Application
    Filed: April 1, 2003
    Publication date: October 7, 2004
    Inventors: David R. Fischell, Robert E. Fischell, Jonathan Harwood
  • Publication number: 20040167602
    Abstract: The present invention relates to an expandable tubular device for implantation in the lumen of a body duct, such as a blood vessel in particular, in order to ensure a passage therein, said device consisting of an assembly of tubular elements aligned along a common longitudinal axis and successively joined together in parts by a plurality of liking members, each tubular element consisting of a strip forming a zigzag corrugation defining bent extreme portions which are sucessively connected together in pairs in opposite directions by rectilinear intermediate portions, the thickness (e) of said strip forming each of the above-mentioned tubular elements (1), measured radially relative to said tubular element, being greater than the width 1 of this strip in said bent potions (2).
    Type: Application
    Filed: March 2, 2004
    Publication date: August 26, 2004
    Inventors: Robert E. Fischell, David R. Fischell, Mark L. Pomeranz, Nicholas A. Green
  • Publication number: 20040153129
    Abstract: A system and method for controlling epilepsy and other neurological disorders by providing electrical stimulation to a patient's brain in response to detected neurological conditions. An implantable device includes a stimulation subsystem coupled to a stimulation electrode to provide responsive electrical brain stimulation in response to an event detected via an on-board processor's analysis of data received from a detection subsystem coupled to a detection electrode located in a different portion of the patient's brain.
    Type: Application
    Filed: July 22, 2003
    Publication date: August 5, 2004
    Applicant: NeuroPace, Inc.
    Inventors: Benjamin D. Pless, Robert E. Fischell, David R. Fischell
  • Publication number: 20040122281
    Abstract: Disclosed is a system and method for treating headaches. The system employs a self-contained, battery operated, readily portable and easy-to-operate head-mounted magnetic depolarizer to generate a transient or time-varying high-intensity magnetic field into and around the user's head or neck. The magnetic depolarizer system can be used to depolarize the neurons of the brain and/or the trigeminal nerve. This type of neuronal depolarization has the capability for terminating migraine or other types of headaches.
    Type: Application
    Filed: December 21, 2002
    Publication date: June 24, 2004
    Applicant: NeuraLieve, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Adrian R.M. Upton
  • Publication number: 20040102836
    Abstract: A stent in the form of a thin-walled, multi-cellular tubular structure is provided. The tubular structure has a longitudinal axis and the stent includes a plurality of circumferential sets of strut members. Each set of the strut members is longitudinally displaced from each other and connected to each other by longitudinally extending links. Each set of the strut members forms a closed and cylindrical portion of the stent. Further, each set of the strut members includes a plurality of connected curve sections and diagonal sections. The sets of the strut members further include end sets of strut members located at each end of the stent and central sets of strut members located between the end sets of the strut members. The diagonal sections of the end sets of the strut members have a center portion and two ends.
    Type: Application
    Filed: November 21, 2003
    Publication date: May 27, 2004
    Inventors: Robert E. Fischell, David R. Fischell, Janet Burpee